US regulators ease label requirements on abortion pill

US regulators Wednesday eased labeling requirements on a medication that induces abortion, a move that women's health advocates said should improve access to abortion, particularly in certain embattled states. The US Food and Drug Administration's decision applies to Mifeprex, also known as mifepristone, which is taken along with another medication called misoprostol to end an early pregnancy. The American College of Obstetricians and Gynecologists applauded the changes.